263 related articles for article (PubMed ID: 30860937)
1. 2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.
Mackler E; Segal EM; Muluneh B; Jeffers K; Carmichael J
J Oncol Pract; 2019 Apr; 15(4):e346-e355. PubMed ID: 30860937
[TBL] [Abstract][Full Text] [Related]
2. Trends in the delivery of care to oncology patients in the United States: Emphasis on the role pharmacists on the healthcare team.
Ignoffo RJ; Knapp KK; Seung A; Brown V; Hough S; Rieband G; Dang TO; Palumbo A; Urmanski A
J Oncol Pharm Pract; 2021 Jan; 27(1):5-13. PubMed ID: 32237957
[TBL] [Abstract][Full Text] [Related]
3. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
4. Women in oncology pharmacy leadership: A white paper.
Shillingburg A; Michaud LB; Schwartz R; Anderson J; Henry DW;
J Oncol Pharm Pract; 2020 Jan; 26(1):175-186. PubMed ID: 31554471
[TBL] [Abstract][Full Text] [Related]
5. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
[TBL] [Abstract][Full Text] [Related]
6. Oncology Pharmacist Opportunities: Closing the Gap in Quality Care.
Vulaj V; Hough S; Bedard L; Farris K; Mackler E
J Oncol Pract; 2018 Jun; 14(6):e403-e411. PubMed ID: 29298114
[TBL] [Abstract][Full Text] [Related]
7. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
[TBL] [Abstract][Full Text] [Related]
8. Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
Smith AT; Kennerly-Shah JM; Kusoski CL
J Oncol Pharm Pract; 2020 Oct; 26(7):1686-1694. PubMed ID: 32865162
[TBL] [Abstract][Full Text] [Related]
9. Precision Medicine in Oncology Pharmacy Practice.
Saadeh C; Bright D; Rustem D
Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
[TBL] [Abstract][Full Text] [Related]
10. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
Arnall JR; Petro R; Patel JN; Kennedy L
J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
[TBL] [Abstract][Full Text] [Related]
11. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist-Driven Oral Oncolytic Medication Education and Consent.
Bowles H; Tawfik B; Abernathy J; Lauer R; Hashemi N; Dayao Z
JCO Oncol Pract; 2020 Oct; 16(10):e1209-e1215. PubMed ID: 32459565
[TBL] [Abstract][Full Text] [Related]
13. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
15. Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents.
Lau G; Alwan L; Chi M; Lentz M; Hone K; Segal E
J Am Pharm Assoc (2003); 2019; 59(4):586-592. PubMed ID: 31036528
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of Health-Care Workers of the Cost and Safety of Oral Oncolytic Agents for Patients: A Survey.
Tompkinson M; Fine K; Gruber D; Abraham I; McBride A
J Adv Pract Oncol; 2020; 11(4):354-365. PubMed ID: 33604096
[TBL] [Abstract][Full Text] [Related]
17. The development of a role description and competency map for pharmacists in an interprofessional care setting.
Benson H; Lucas C; Benrimoj SI; Williams KA
Int J Clin Pharm; 2019 Apr; 41(2):391-407. PubMed ID: 30879217
[TBL] [Abstract][Full Text] [Related]
18. Impact of clinical pharmacists in outpatient oncology practices: A review.
Gatwood J; Gatwood K; Gabre E; Alexander M
Am J Health Syst Pharm; 2017 Oct; 74(19):1549-1557. PubMed ID: 28947527
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of pharmacists' roles in the era of expanding scopes of practice.
Schindel TJ; Yuksel N; Breault R; Daniels J; Varnhagen S; Hughes CA
Res Social Adm Pharm; 2017; 13(1):148-161. PubMed ID: 27061142
[TBL] [Abstract][Full Text] [Related]
20. Impact of a Statewide Oral Oncolytic Initiative on Five Participating Practices.
Mackler E; Scappaticci GB; Salgado TM; Petersen L; Davis EJ; Peltier E; Griggs JJ; Sabo RT; Farris KB
J Oncol Pract; 2018 May; 14(5):e304-e309. PubMed ID: 29641272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
